Anti-CXCL13 antibodies for treating autoimmune diseases and cancer

• 收藏
• 分享

专利权人:

I-Mab Biopharma US Limited

发明人:

GU, Haijuan,YANG, Qiumei

申请号：

AU2019342180

公开号：

AU2019342180A1

申请日:

2019.09.18

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Provided are antibodies or fragments thereof having binding specificity to the human chemokine (C-X-C motif) ligand 13 (CXCL 13) protein. In various examples, the antibodies or fragments thereof include a VH and VL CDRs as disclosed herein, or variants thereof. Methods of using the antibodies or fragments thereof for treating autoimmune diseases and disorders are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/